ClinicalTrials.gg
Active, not recruitingNCT04496687Updated May 6, 2026

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

An observational study in Spontaneous Coronary Artery Dissection, sponsored by SCAD Alliance. Active, not recruiting at 31 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by SCAD Alliance · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.

Enrollment
2nd of 10
2,000 · median 675
Started
2019
the only one that year
Observational
10 of 13
6 open now
Registered
8th of 13
by date
Lead sponsor
1 of 13
SCAD Alliance

Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is the 2nd largest by enrollment of the 10 observational ones that give a count, is the only one that started in 2019, is one of 10 observational ones, and was the 8th registered.

Coronary Artery Dissection, Spontaneous

28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.

Browse Coronary Artery Dissection, Spontaneous studies →

Open to participants now

8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, or all of them as a file.
02

Study summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD.

The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.

Read the detailed description

Spontaneous Coronary Artery Dissection (SCAD) is an under-diagnosed cause of acute coronary syndrome (ACS), myocardial infarction (MI) and sudden cardiac arrest. The inner lining of the coronary artery splits and allows blood to seep into the adjacent layer, forming a blockage (hematoma), or the artery continues to tear, creating a flap of tissue that blocks blood flow in the artery.

SCAD strikes generally healthy, younger individuals (average age 42) who do not have traditional cardiac risk factors. Warning signs of SCAD encompass the full range of ACS and MI symptoms, from vague to classic. The cause of SCAD is currently unknown and the psychosocial impact of SCAD is traumatizing. The work of the iSCAD Registry will encompass the physical and psychosocial study of SCAD.

03

Conditions studied

  • Spontaneous Coronary Artery Dissection

Keywords

  • spontaneous coronary artery dissection (SCAD)
  • myocardial infarction
  • sudden cardiac arrest
  • acute coronary syndrome
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Spontaneous coronary artery dissection (SCAD) is defined as the non-traumatic, non-iatrogenic separation of the coronary arterial wall by intramural hemorrhage creating a false lumen, with or without an intimal tear. SCAD nearly always presents as an acute myocardial infarction. The prevalence of SCAD varies depending on the population studied. A goal of iSCAD Registry is to expand diversity of race, ethnicity, and sex of study participants. The mean age of SCAD presentation is 45-53 years of age, and appears to primarily affect women.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants with a new diagnosis of SCAD or a history of confirmed or suspected SCAD will be prospectively recruited from either:

  1. Inpatient wards of the enrolling medical centers during the acute presentation of SCAD, or
  2. Outpatient cardiovascular clinics of enrolling medical centers.

Participants must be:

  • 18 years of age or older
  • Diagnosis of SCAD or history of SCAD based on coronary angiography, either catheter-based or coronary CTA
  • Suspected SCAD by coronary angiography

Exclusion criteria

Exclusion Criteria:

  1. Coronary dissection in association with atherosclerosis or as a result of iatrogenic injury
  2. Inability to provide
  3. Inability to complete study-related patient questionnaires
  4. Inability to understand and complete patient questionnaires independently
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
2,000 participants (actual)
Target follow-up
3 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Descriptive Data

    Participant demographic, historical, clinical characteristics, and treatment data

    Time frame: Continuous time frame following index event for an average of 3 years from study contact date

  2. Clinical Outcomes

    Prospectively collected long-term outcomes including recurrent myocardial infarction, hospitalization, heart failure, stroke or transient ischemic attack, arrhythmia, and all cause mortality

    Time frame: Continuous time frame following index event for an average of 3 years from study contact date

  3. Psychosocial Outcomes

    Prospectively collected data on participant's mental health using validated questionnaires

    Time frame: Continuous time frame following index event for an average of 3 years from study contact date

07

Study locations

31 sites
08

References and documents

Publications

  • Chi G, Kim ESH, Gornik HL, Grodzinsky A, Wells BJ, Lewey J, Kadian-Dodov D, Taylor AM, Hess CN, Tam LM, Mauricio R, Henkin S, Lindley KJ, Orford JL, Tolani S, Alkhalfan F, Reyes C, Gibson CM, Leon KK, Naderi S, Scott NS, Wood MJ. Patient characteristics and incidence of in-hospital events in spontaneous coronary artery dissection and suspected concurrent Takotsubo syndrome: A report of the iSCAD registry. Am Heart J Plus. 2026 May 9;66:100793. doi: 10.1016/j.ahjo.2026.100793. eCollection 2026 Jun. PubMed 42199296 ↗
  • Sumner JA, Kim ESH, Wood MJ, Chi G, Nolen J, Grodzinsky A, Gornik HL, Kadian-Dodov D, Wells BJ, Hess CN, Lewey J, Tam L, Henkin S, Orford J, Wells G, Kumbhani DJ, Lindley KJ, Gibson CM, Leon KK, Naderi S. Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry. J Am Heart Assoc. 2024 Apr 2;13(7):e032819. doi: 10.1161/JAHA.123.032819. Epub 2024 Mar 27. PubMed 38533943 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2019 (actual). Primary completion is estimated for Dec 2026, 93 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2020
First posted
Aug 3, 2020
StartActual
Mar 8, 2019
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
May 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04496687
Lead sponsor
SCAD Alliance
Collaborators
PERFUSE Study Group
Responsible party
Sponsor
First posted
Aug 3, 2020
Start date
Mar 8, 2019
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 6, 2026

Study contacts

Esther Kim, MD
study chair · Chair, Steering Committee
Malissa Wood, MD
principal investigator · Member, Steering Committee
Sahar Naderi, MD
principal investigator · Member, Steering Committee

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion